Dexpanthenol

Identification

Name
Dexpanthenol
Accession Number
DB09357
Description

Dexpanthenol is an alcohol derivative of pantothenic acid, a component of the B complex vitamins and an essential component of a normally functioning epithelium. Dexpanthenol is enzymatically cleaved to form pantothenic acid, which is an essential component of Coenzyme A, which acts as a cofactor in many enzymatic reactions that are important for protein metabolism in the epithelium2.

Due to its good penetration and high local concentrations, dexpanthanol is used in many topical products, such as ointments and lotions for treatment of dermatological conditions to relieve itching or promote healing. Dermatological effects of the topical use of dexpanthenol include increased fibroblast proliferation and accelerated re-epithelialization in wound healing. Furthermore, it acts as a topical protectant, moisturizer, and has demonstrated anti-inflammatory properties 3.

Dexpanthenol is also available as a racemic mixture containing both the dextrorotatory form (dexpanthenol) and the levorotatory form (levopanthenol) as Panthenol. While pantothenic acid is optically active, only the dextrorotatory form (dexpanthenol) is biologically active.

Type
Small Molecule
Groups
Approved
Structure
Thumb
Weight
Average: 205.2515
Monoisotopic: 205.131408101
Chemical Formula
C9H19NO4
Synonyms
  • (+)-Panthenol
  • (2R)-2,4-dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutanamide
  • Bepanthen
  • Bepanthene
  • Bepantol
  • D-panthenol
  • D-panthenol 50
  • D-Pantothenol
  • D-Pantothenyl alcohol
  • D(+)-Panthenol
  • Dexpantenol
  • Dexpanthenol
  • Dexpanthenolum
  • Pantol
  • Pantothenyl alcohol
  • Provitamin B
External IDs
  • 201-327-3
  • BAY 81-2996
  • NSC-302962

Pharmacology

Indication

Injection: Prophylactic use immediately after major abdominal surgery to minimize the possibility of paralytic ileus. Intestinal atony causing abdominal distention; postoperative or postpartum retention of flatus, or postoperative delay in resumption of intestinal motility; paralytic ileus.

Topical: This medication is used as a moisturizer to treat or prevent dry, rough, scaly, itchy skin and minor skin irritations (e.g., diaper rash, skin burns from radiation therapy).

Associated Conditions
Associated Therapies
Contraindications & Blackbox Warnings
Learn about our commercial Contraindications & Blackbox Warnings data.
Learn More
Pharmacodynamics

Pantothenic acid is a precursor of coenzyme A, which serves as a cofactor for a variety of enzyme-catalyzed reactions involving transfer of acetyl groups. The final step in the synthesis of acetylcholine consists of the choline acetylase transfer of acetyl group from acetylcoenzyme A to choline. Acetylcholine is the neurohumoral transmitter in the parasympathetic system and as such maintains the normal functions of the intestine. Decrease in acetylcholine content would result in decreased peristalsis and in extreme cases adynamic ileus.

Mechanism of action

Dexpanthenol is an alcohol derivative of pantothenic acid, a component of the B complex vitamins and an essential component of a normally functioning epithelium. Dexpanthenol is enzymatically cleaved to form pantothenic acid, which is an essential component of Coenzyme A, which acts as a cofactor in many enzymatic reactions that are important for protein metabolism in the epithelium2.

Dermatological effects of the topical use of dexpanthenol include increased fibroblast proliferation and accelerated re-epithelialization in wound healing. Furthermore, it acts as a topical protectant, moisturizer, and has demonstrated anti-inflammatory properties 3.

Absorption

Dexpanthenol is soluble in water and alcohol, although insoluble in fats and oil based substances. With the appropriate vehicle, Dexpanthenol is easily penetrated into the skin. Rate of penetration and absorption is reduced when Dexpanthenol is administered as an oil/water formula.

Volume of distribution

Dexpanthenol is readily converted to pantothenic acid which is widely distributed into body tissues, mainly as coenzyme A. Highest concentrations are found in the liver, adrenal glands, heart, and kidneys.

Protein binding

Plasma protein binding have not been reported.

Metabolism

Dexpanthenol is readily converted to pantothenic acid which is widely distributed into body tissues, mainly as coenzyme A.

Hover over products below to view reaction partners

Route of elimination

Milk of nursing mothers receiving a normal diet contains about 2 ug of pantothenic acid per mL. About 70% of an oral dose of pantothenic acid is excreted unchanged in urine and about 30% in feces.

Half-life

Half life have not been reported

Clearance
Not Available
Adverse Effects
Learn about our commercial Adverse Effects data.
Learn More
Toxicity

Mouse LD50 : 9gm/kg (Intraperitoneal) Mouse: LD50 7gm/kg (Intravenous) Mouse: LD50 15gm/kg (Oral) Rabbit LD50 4gm/kg (Oral)

Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
DrugInteraction
AbacavirAbacavir may decrease the excretion rate of Dexpanthenol which could result in a higher serum level.
AcarboseAcarbose may decrease the excretion rate of Dexpanthenol which could result in a higher serum level.
AceclofenacAceclofenac may decrease the excretion rate of Dexpanthenol which could result in a higher serum level.
AcemetacinAcemetacin may decrease the excretion rate of Dexpanthenol which could result in a higher serum level.
AcetaminophenAcetaminophen may decrease the excretion rate of Dexpanthenol which could result in a higher serum level.
AcetazolamideAcetazolamide may increase the excretion rate of Dexpanthenol which could result in a lower serum level and potentially a reduction in efficacy.
Acetylsalicylic acidAcetylsalicylic acid may decrease the excretion rate of Dexpanthenol which could result in a higher serum level.
AclidiniumAclidinium may decrease the excretion rate of Dexpanthenol which could result in a higher serum level.
AcrivastineDexpanthenol may decrease the excretion rate of Acrivastine which could result in a higher serum level.
AcyclovirAcyclovir may decrease the excretion rate of Dexpanthenol which could result in a higher serum level.
Additional Data Available
  • Extended Description
    Extended Description

    Extended description of the mechanism of action and particular properties of each drug interaction.

    Learn more
  • Severity
    Severity

    A severity rating for each drug interaction, from minor to major.

    Learn more
  • Evidence Level
    Evidence Level

    A rating for the strength of the evidence supporting each drug interaction.

    Learn more
  • Action
    Action

    An effect category for each drug interaction. Know how this interaction affects the subject drug.

    Learn more
Food Interactions
No interactions found.

Products

Active Moieties
NameKindUNIICASInChI Key
Pantothenic acidunknown19F5HK273779-83-4GHOKWGTUZJEAQD-ZETCQYMHSA-N
International/Other Brands
Cozyme / Ilopan / Motilyn / Panadon / Panthoderm / Synapan / Thenalton / Zentinic
Brand Name Prescription Products
NameDosageStrengthRouteLabellerMarketing StartMarketing EndRegionImage
DexpanthenolInjection, solution250 mg/1mLIntramuscular; IntravenousAmerican Regent1993-08-202016-11-09US flag
Additional Data Available
  • Application Number
    Application Number

    A unique ID assigned by the FDA when a product is submitted for approval by the labeller.

    Learn more
  • Product Code
    Product Code

    A governmentally-recognized ID which uniquely identifies the product within its regulatory market.

    Learn more
Over the Counter Products
NameDosageStrengthRouteLabellerMarketing StartMarketing EndRegionImage
BabysonsOintment50 mg/1gTopicalLaboratorios Quimica Son's, S.A. de C.V2020-06-15Not applicableUS flag
Eros Aqua Sensations and Care WomanGel0.5 g/100mLTopicalMEGASOL COSMETIC GMBH2012-10-012018-01-17US flag
Perfect Pore Clean ILiquid0.001 g/1mLTopicalAmi Cosmetic Co.,Ltd.2014-04-142019-01-15US flag
Vitalizer WhiteLiquid0.0005 g/1mLTopicalAmi Cosmetic Co.,Ltd.2014-04-142019-01-15US flag
Yozum Well Being Hair ColorLiquid0.2 g/100gTopicalYozum Korea2014-12-08Not applicableUS flag
Additional Data Available
  • Application Number
    Application Number

    A unique ID assigned by the FDA when a product is submitted for approval by the labeller.

    Learn more
  • Product Code
    Product Code

    A governmentally-recognized ID which uniquely identifies the product within its regulatory market.

    Learn more
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
Adult Infuvite Multiple VitaminsDexpanthenol (15 mg/10mL) + Ascorbic acid (200 mg/10mL) + Biotin (60 ug/10mL) + Cholecalciferol (200 [iU]/10mL) + Cyanocobalamin (5 ug/10mL) + Riboflavin 5'-phosphate sodium (3.6 mg/10mL) + Folic acid (600 ug/10mL) + Nicotinamide (40 mg/10mL) + Phylloquinone (150 ug/10mL) + Pyridoxine hydrochloride (6 mg/10mL) + Thiamine hydrochloride (6 mg/10mL) + Vitamin A palmitate (3300 [iU]/10mL) + alpha-Tocopherol acetate (10 [iU]/10mL)Injection, solutionIntravenousSandoz Manufacturing Inc2003-06-16Not applicableUS flag
Adult Infuvite Multiple VitaminsDexpanthenol (15 mg/10mL) + Ascorbic acid (200 mg/10mL) + Biotin (60 ug/10mL) + Cholecalciferol (200 [iU]/10mL) + Cyanocobalamin (5 ug/10mL) + Riboflavin 5'-phosphate sodium (3.6 mg/10mL) + Folic acid (600 ug/10mL) + Nicotinamide (40 mg/10mL) + Phylloquinone (150 ug/10mL) + Pyridoxine hydrochloride (6 mg/10mL) + Thiamine hydrochloride (6 mg/10mL) + Vitamin A palmitate (3300 [iU]/10mL) + alpha-Tocopherol acetate (10 [iU]/10mL)Injection, solutionIntravenousSandoz Manufacturing Inc2005-05-18Not applicableUS flag
Adult Infuvite Multiple VitaminsDexpanthenol (15 mg/10mL) + Ascorbic acid (200 mg/10mL) + Biotin (60 ug/10mL) + Cholecalciferol (200 [iU]/10mL) + Cyanocobalamin (5 ug/10mL) + Riboflavin 5'-phosphate sodium (3.6 mg/10mL) + Folic acid (600 ug/10mL) + Nicotinamide (40 mg/10mL) + Phylloquinone (150 ug/10mL) + Pyridoxine hydrochloride (6 mg/10mL) + Thiamine hydrochloride (6 mg/10mL) + Vitamin A palmitate (3300 [iU]/10mL) + alpha-Tocopherol acetate (10 [iU]/10mL)Injection, solutionIntravenousSandoz Manufacturing Inc2005-05-18Not applicableUS flag
Adult Infuvite Multiple VitaminsDexpanthenol (15 mg/10mL) + Ascorbic acid (200 mg/10mL) + Biotin (60 ug/10mL) + Cholecalciferol (200 [iU]/10mL) + Cyanocobalamin (5 ug/10mL) + Riboflavin 5'-phosphate sodium (3.6 mg/10mL) + Folic acid (600 ug/10mL) + Nicotinamide (40 mg/10mL) + Phylloquinone (150 ug/10mL) + Pyridoxine hydrochloride (6 mg/10mL) + Thiamine hydrochloride (6 mg/10mL) + Vitamin A palmitate (3300 [iU]/10mL) + alpha-Tocopherol acetate (10 [iU]/10mL)Injection, solutionIntravenousSandoz Manufacturing Inc2003-06-16Not applicableUS flag
Alsimine W Vitamins A DDexpanthenol (5 mg) + Dexpanthenol (400 unit) + Calcium (13 mg) + Cyanocobalamin (10 mcg) + Ferrous gluconate (16 mg) + Riboflavin 5'-phosphate sodium (2 mg) + Nicotinamide (40 mg) + Pyridoxine hydrochloride (3 mg) + Thiamine hydrochloride (4.5 mg) + Vitamin A (10000 unit)Capsule; LiquidOralAlsi Cie Ltee1978-12-312003-05-21Canada flag
Alsimine W Vitamins A DDexpanthenol (5 mg) + Dexpanthenol (400 unit) + Calcium (13 mg) + Cyanocobalamin (10 mcg) + Ferrous gluconate (16 mg) + Riboflavin 5'-phosphate sodium (2 mg) + Nicotinamide (40 mg) + Pyridoxine hydrochloride (3 mg) + Thiamine hydrochloride (4.5 mg) + Vitamin A (10000 unit)Capsule; LiquidOralAlsi Cie Ltee1978-12-312003-05-21Canada flag
Aquasol A CreamDexpanthenol (21.4 mg) + Vitamin A palmitate (7055 unit)CreamTopicalRhone Poulenc Rorer1993-12-311998-08-12Canada flag
Atomy Herbal Hair TonicDexpanthenol (0.4 mL/200mL) + Levomenthol (0.6 mL/200mL) + Salicylic acid (0.5 mL/200mL)LiquidTopicalAtomy Co., Ltd.2010-04-29Not applicableUS flag
B Complex W C and B12 InjDexpanthenol (60 mg) + Ascorbic acid (500 mg) + Cyanocobalamin (10 mg) + Riboflavin 5'-phosphate sodium (50 mg) + Nicotinamide (1.25 g) + Pyridoxine hydrochloride (50 mg) + Thiamine hydrochloride (500 mg)LiquidIntramuscular; IntravenousE L Stickley And Co Ltd.1963-12-311996-09-09Canada flag
B Vitamin Compound With B12 ThunasDexpanthenol (.5 mg) + Cyanocobalamin (.11 mcg) + Nicotinamide (.8 mg) + Riboflavin (.15 mg) + Thiamine mononitrate (.15 mg)LiquidOralThuna Herbal Remedies Ltd.1984-05-312002-10-16Canada flag
Unapproved/Other Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
Atomy Herbal Hair TonicDexpanthenol (0.4 mL/200mL) + Levomenthol (0.6 mL/200mL) + Salicylic acid (0.5 mL/200mL)LiquidTopicalAtomy Co., Ltd.2010-04-29Not applicableUS flag
B-ComboDexpanthenol (1 mg/1mL) + Mecobalamin (1 mg/1mL) + Nicotinamide (1 mg/1mL) + Pyridoxine (1 mg/1mL) + Riboflavin (1 mg/1mL) + Thiamine chloride (1 mg/1mL)InjectionIntramuscularPerdido Key Health And Wellness Inc2015-11-23Not applicableUS flag
B-plex 100Dexpanthenol (2 mg/1mL) + Riboflavin 5'-phosphate sodium (2 mg/1mL) + Nicotinamide (100 mg/1mL) + Pyridoxine hydrochloride (2 mg/1mL) + Thiamine hydrochloride (100 mg/1mL)Injection, solutionIntramuscular; IntravenousMerit Pharmaceutical2012-01-01Not applicableUS flag
Crazyskin BeersDexpanthenol (0.2 g/100g) + Levomenthol (0.3 g/100g) + Salicylic acid (0.25 g/100g)ShampooTopicalCrazy Skin Co., Ltd.2020-02-22Not applicableUS flag
DexpanthenolDexpanthenol (250 mg/1mL)Injection, solutionIntramuscular; IntravenousAmerican Regent1993-08-202016-11-09US flag
Ellis TonicDexpanthenol (3 mg/15mL) + Cyanocobalamin (2 ug/15mL) + Magnesium sulfate (0.7 mg/15mL) + Manganese sulfate (0.7 mg/15mL) + Nicotinamide (7 mg/15mL) + Pyridoxine hydrochloride (0.7 mg/15mL) + Riboflavin (0.6 mg/15mL) + Thiamine hydrochloride (0.5 mg/15mL) + Zinc sulfate, unspecified form (5 mg/15mL)LiquidOralBreckenridge Pharmaceutical, Inc.2001-01-012011-11-01US flag
HASOL Anagen Hair TonicDexpanthenol (0.002 1/100mL) + Levomenthol (0.003 1/100mL) + Salicylic acid (0.0025 1/100mL)LiquidTopicalEcomine Co., Ltd.2016-03-28Not applicableUS flag
HASOL Anagen ScalpDexpanthenol (0.002 1/500g) + Levomenthol (0.003 1/500g) + Salicylic acid (0.0025 1/500g)ShampooTopicalEcomine Co., Ltd.2016-03-28Not applicableUS flag
HASOL Anti Hair LossDexpanthenol (0.002 1/500g) + Levomenthol (0.003 1/500g) + Salicylic acid (0.0025 1/500g)ShampooTopicalEcomine Co., Ltd.2016-03-31Not applicableUS flag
HASOL Vital For Hair-Loss TonicDexpanthenol (0.002 1/100mL) + Levomenthol (0.003 1/100mL) + Salicylic acid (0.0025 1/100mL)LiquidTopicalEcomine Co., Ltd.2016-04-01Not applicableUS flag

Categories

ATC Codes
D03AX03 — DexpanthenolS01XA12 — DexpanthenolA11HA30 — Dexpanthenol
Drug Categories
Chemical TaxonomyProvided by Classyfire
Description
This compound belongs to the class of organic compounds known as secondary alcohols. These are compounds containing a secondary alcohol functional group, with the general structure HOC(R)(R') (R,R'=alkyl, aryl).
Kingdom
Organic compounds
Super Class
Organic oxygen compounds
Class
Organooxygen compounds
Sub Class
Alcohols and polyols
Direct Parent
Secondary alcohols
Alternative Parents
Propargyl-type 1,3-dipolar organic compounds / Carboximidic acids / Alkanolamines / Primary alcohols / Organopnictogen compounds / Hydrocarbon derivatives
Substituents
Aliphatic acyclic compound / Alkanolamine / Carboximidic acid / Carboximidic acid derivative / Hydrocarbon derivative / Organic 1,3-dipolar compound / Organic nitrogen compound / Organonitrogen compound / Organopnictogen compound / Primary alcohol
Molecular Framework
Aliphatic acyclic compounds
External Descriptors
monocarboxylic acid amide, amino alcohol (CHEBI:27373)

Chemical Identifiers

UNII
1O6C93RI7Z
CAS number
81-13-0
InChI Key
SNPLKNRPJHDVJA-ZETCQYMHSA-N
InChI
InChI=1S/C9H19NO4/c1-9(2,6-12)7(13)8(14)10-4-3-5-11/h7,11-13H,3-6H2,1-2H3,(H,10,14)/t7-/m0/s1
IUPAC Name
(2R)-2,4-dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutanamide
SMILES
CC(C)(CO)[[email protected]@H](O)C(=O)NCCCO

References

General References
  1. Slyshenkov VS, Dymkowska D, Wojtczak L: Pantothenic acid and pantothenol increase biosynthesis of glutathione by boosting cell energetics. FEBS Lett. 2004 Jul 2;569(1-3):169-72. [PubMed:15225628]
  2. Proksch E, de Bony R, Trapp S, Boudon S: Topical use of dexpanthenol: a 70th anniversary article. J Dermatolog Treat. 2017 Dec;28(8):766-773. doi: 10.1080/09546634.2017.1325310. Epub 2017 May 14. [PubMed:28503966]
  3. Biro K, Thaci D, Ochsendorf FR, Kaufmann R, Boehncke WH: Efficacy of dexpanthenol in skin protection against irritation: a double-blind, placebo-controlled study. Contact Dermatitis. 2003 Aug;49(2):80-4. [PubMed:14641355]
  4. DRUGS.COM [Link]
  5. Webmd [Link]
  6. Pubchem [Link]
  7. ChemIDplus [Link]
KEGG Drug
D00193
KEGG Compound
C05944
PubChem Compound
131204
PubChem Substance
347827835
ChemSpider
115991
RxNav
22701
ChEMBL
CHEMBL1200979
ZINC
ZINC000001530303
RxList
RxList Drug Page
Drugs.com
Drugs.com Drug Page
Wikipedia
Panthenol

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
4CompletedBasic ScienceCell Proliferation / Gene Expression / Wound Healing1
4CompletedTreatmentErythemas / Skin Recovery1
4CompletedTreatmentSkin Recovery2
4CompletedTreatmentWound Healing1
3CompletedSupportive CarePhotodamaged Skin1
3CompletedTreatmentBreast Cancer1
3CompletedTreatmentHbA1c Level / Plasma Homocysteine1
3CompletedTreatmentHydatidiform Mole1
3CompletedTreatmentLack or Loss Appetite Nonorganic Origin1
3CompletedTreatmentNasal Congestion1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
Capsule; liquidOral
CreamTopical
LiquidTopical
SolutionIntramuscular; Intravenous25 mg/2ml
Ointment
OintmentTopical50 mg/1g
Injection, solution1 mg/1mL
SyrupOral5 mg/5ml
Solution2.5 mg/ml
Solution500 mg
Tablet, coated25 mg
ElixirOral
Powder, for solutionIntramuscular; Intravenous
Powder, for solutionIntravenous
SolutionIntramuscular; Intravenous; Subcutaneous500 mg/2ml
OintmentNasal; Ophthalmic50 mg/g
SolutionOral50 mg/g
Lozenge100 mg
Ointment50 mg/g
GelOphthalmic1 g
GelOphthalmic50 mg/g
GelOphthalmic120 mg/0.6mL
GelOphthalmic30 mg/0.6mL
GelOphthalmic60 mg/0.6mL
Solution / drops; suspension / dropsOphthalmic50 mg/mL
Solution / drops; suspension / dropsOphthalmic30 mg/0.6mL
Solution / drops; suspension / dropsOphthalmic60 mg/0.6mL
SprayTopical5 g/100mL
OintmentTopical5 %
Injection, solutionIntramuscular; Intravenous250 mg/1mL
CreamTopical50 mg/g
GelOphthalmic5 %
Solution / drops; suspension / dropsOphthalmic30 mg/mL
LiquidOral
GelTopical0.5 g/100mL
LiquidIntramuscular; Intravenous
CreamTopical50 mg
OintmentTopical5 mg
GelTopical1.5 %
InjectionIntramuscular
Injection, powder, lyophilized, for solutionIntravenous
KitIntravenous
Solution; sprayNasal1 g/100mL
Solution; sprayNasal5 g/100mL
Solution; sprayNasal50 mg/1mL
SolutionIntravenous140 mcg
LiquidIntravenous
SprayNasal50 mg/ml
ShampooTopical
SolutionIntramuscular; Intravenous
SolutionBuccal; Oropharyngeal1.1 g
Solution / drops; suspension / dropsOphthalmic50 mg
Injection, solutionIntramuscular; Intravenous500 mg
Cream5 %
Ointment5 %
SolutionOral5 %
OintmentOphthalmic5 g
CreamTopical100 g
CreamTopical20 g
CreamTopical50 g
CreamNasal50 mg/g
CreamTopical5 G/100G
CreamTopical5 %
Injection, solutionIntramuscular; Intravenous; Subcutaneous500 mg
Cream
Injection, solutionIntravenous
SolutionOral100 mg
PatchTopical
LiquidTopical0.001 g/1mL
SyrupOral1500 IU
Syrup1250 IU
Syrup150 ml
Solution / dropsOphthalmic30 mg/ml
Gel15 mg
Liquid; tabletOral
Tablet, coated2 mg
Syrup2500 IU
Syrup100 iu/5mL
Powder, for solution3500 IU
Injection, solution10 mg/2mL
SyrupOral1250 IU/5mL
Capsule75 mg
LiquidTopical0.0005 g/1mL
InjectionIntramuscular; Intravenous
InjectionIntravenous
Injection, solutionIntramuscular; Intravenous
Spray, meteredNasal0.5 mg/ml
LiquidTopical0.2 g/100g
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility121.0 mg/mLALOGPS
logP-1ALOGPS
logP-1.7ChemAxon
logS-0.23ALOGPS
pKa (Strongest Acidic)12.69ChemAxon
pKa (Strongest Basic)-2.4ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count4ChemAxon
Hydrogen Donor Count4ChemAxon
Polar Surface Area89.79 Å2ChemAxon
Rotatable Bond Count6ChemAxon
Refractivity51.88 m3·mol-1ChemAxon
Polarizability21.87 Å3ChemAxon
Number of Rings0ChemAxon
Bioavailability1ChemAxon
Rule of FiveYesChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
GC-MS Spectrum - GC-MS (4 TMS)GC-MSsplash10-0f8a-1921000000-f1d6cd175435f0634e26
GC-MS Spectrum - GC-MS (3 TMS)GC-MSsplash10-0ar9-0940000000-60184a3322815ca33b8c
Predicted GC-MS Spectrum - GC-MSPredicted GC-MSNot Available
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot Available

Drug created on November 30, 2015 12:10 / Updated on October 24, 2020 01:31

Logo pink
Are you a
new drug developer?
Contact us to learn more about our customized products and solutions.
Logo pink
Stay in the know!
As part of our commitment to providing the most up-to-date drug information, we will be releasing #DrugBankUpdates with our newly added curated drug pages.
#DrugBankUpdates